Julia Chapman

High-Dose Parenteral Ascorbate Enhanced Chemosensitivity of Ovarian Cancer and Reduced Toxicity of Chemotherapy

Yan Ma, Julia Chapman, Mark Levine et al. · Science Translational Medicine · 2014 · 484 citations

Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: A Gynecologic Oncology Group study

Gini F. Fleming, Michael W. Sill, Kathleen M. Darcy et al. · Gynecologic Oncology · 2009 · 295 citations · Full text

Phase Ii Trial, Medicine, Cancer Management +6

Estrogen replacement in surgical stage I and II endometrial cancer survivors

Julia Chapman, Philip J. DiSaia, Kathryn Osann et al. · American Journal of Obstetrics and Gynecology · 1996 · 149 citations

Gynecologic Surgery, Gynecological Surgery, Surgical Stage +9

The Use of Antioxidants with First-Line Chemotherapy in Two Cases of Ovarian Cancer

Jeanne Drisko, Julia Chapman, Verda J. Hunter · Journal of the American College of Nutrition · 2003 · 146 citations

Oral Antioxidant Therapy, Chemoprevention Strategy, Medicine +15

Heightened Expression of Cyclooxygenase-2 and Peroxisome Proliferator-Activated Receptor-δ in Human Endometrial Adenocarcinoma

Beverly J. Tong, Jian Tan, Lovella Tajeda et al. · Neoplasia · 2000 · 129 citations · Full text